Horvath; Judit

Patent Applications and Registrations

Patent applications and USPTO patent grants for Horvath; Judit.The latest application filed is for "stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof".

Company Profile

3.9.8

Horvath; Judit - Menlo Park CA
Horvath; Judit - Cupertino CA
Horvath; Judit - Budapest HU
Horvath, Judit - Pecs HU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof Grant 10,765,677 - Horvath , et al. Sep	2020-09-08
Stable And Soluble Formulations Of Receptor Tyrosine Kinase Inhibitors, And Methods Of Preparation Thereof App 20190365757 - Horvath; Judit ; et al.	2019-12-05
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof Grant 10,363,255 - Horvath , et al.	2019-07-30
Stable And Soluble Formulations Of Receptor Tyrosine Kinase Inhibitors, And Methods Of Preparation Thereof App 20180147204 - Horvath; Judit ; et al.	2018-05-31
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant Grant 9,968,603 - Astafieva , et al. May 15, 2	2018-05-15
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof Grant 9,895,369 - Horvath , et al. February 20, 2	2018-02-20
Stable And Soluble Formulations Of Receptor Tyrosine Kinase Inhibitors, And Methods Of Preparation Thereof App 20170071938 - Horvath; Judit ; et al.	2017-03-16
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof Grant 9,474,756 - Horvath , et al. October 25, 2	2016-10-25
Stable and Soluble Formulations of Receptor Tyrosine Kinase Inhibitors, and Methods of Preparation Thereof App 20160038488 - Horvath; Judit ; et al.	2016-02-11
Systems for Sustained Intraocular Delivery of Low Solubility Compounds from a Port Delivery System Implant App 20140276482 - Astafieva; Irina ; et al.	2014-09-18
Process for the preparation of 17-hydroxy-6.beta.,7.beta.;15.beta.,16.beta.-bismethylene-17.alpha.-pregn- -4-ene-3-one-21-carboxylic acid .gamma.-lactone and key intermediates for this process Grant 8,450,476 - Galik , et al. May 28, 2	2013-05-28
Industrial process for the preparation of 17-hydroxy-6beta,7beta;15beta, 16beta-bismethylene-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid y-lactone and key intermediates for this process Grant 8,309,712 - Soros , et al. November 13, 2	2012-11-13
Industrial Process for the Preparation of 17-Hydroxy-6Beta, 7Beta; 15Beta, 16Beta-Bismethylene-3-Oxo-17Alpha-Pregn-4-Ene-21-Carboxylic Acid Y-Lactone and Key Intermediates for this Process App 20080200668 - Soros; Bela ; et al.	2008-08-21
Process for the Preparation of 17-Hydroxy-6Beta, 7Beta; 15Beta, 16Beta-Bismethylene- 17Alpha-Pregn-4-Ene-3-One-21-Carboxylic Acid Y-Lactone and Key Intermediates for this Process App 20080194812 - Galik; Gyorgy ; et al.	2008-08-14
Process for the preparation of pharmaceutical compositions possessing neurogenic or non-neurogenic anti-inflammatory as well as analgetic effects App 20010009899 - Keri, Gyorgy ; et al.	2001-07-26
Analogs of growth hormone releasing factor (GRF) and a method for the preparation thereof Grant 5,023,322 - Kovacs , et al. June 11, 1	1991-06-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.